sarcopenia and glp 1 Sarcopenia‐related changes in serum GLP‐1 level affect myogenic differentiation - Huang - 2024 - Journal of Cachexia, Muscle Adverse effects of GLP-1 class
Description
GLP-1 receptor agonists are used for type 2 diabetes and weight loss, and mimic the way the naturally occurring hormone, GLP-1, acts in the body
Similar studies are ongoing in patients with metabolic liver diseases, such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), based on the known ability of GLP-1 to reduce fat levels in the liver
Exec SummaryDanuglipron is an experimental weight loss medication being developed by Pfizer
Coverage looks at service structure, pricing presentation, medical review steps, pharmacy fulfillment, and ongoing membership terms
